Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED)
Clinical trial NCT00812266 · TERMINATED
Trial details
- NCT number
- NCT00812266
- Sponsor
- Danish Oncological Lung Cancer Group
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.